Dr Reddy's Q3 Profit Up 2% to Rs 1,413 cr - Business News
Dr Reddy's Laboratories reported a 2% increase in net profit to Rs 1,413 crore in Q3 FY25, driven by growth in the NRT business and operational efficiencies.
New Delhi, Jan 23 (PTI) Dr Reddy's Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third quarter ended December 31, 2024.
The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal.
Revenue increased to Rs 8,359 crore in the quarter from Rs 7,215 crore in the year-ago period, Dr Reddy's Laboratories said in a statement.
"We delivered double-digit growth aided by our newly acquired NRT business, new launches and improved operational efficiencies. We remain committed to addressing patient needs by advancing healthcare through access, affordability and innovation," company's Co-Chairman & MD G V Prasad said.
Dr Reddy's shares on Thursday ended 0.54 per cent down at Rs 1,289.35 apiece on BSE.
The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal.
Revenue increased to Rs 8,359 crore in the quarter from Rs 7,215 crore in the year-ago period, Dr Reddy's Laboratories said in a statement.
"We delivered double-digit growth aided by our newly acquired NRT business, new launches and improved operational efficiencies. We remain committed to addressing patient needs by advancing healthcare through access, affordability and innovation," company's Co-Chairman & MD G V Prasad said.
Dr Reddy's shares on Thursday ended 0.54 per cent down at Rs 1,289.35 apiece on BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.10 (+ 18.94)
- 352105814
- GTL Infrastructure
- 1.50 (+ 7.14)
- 20982285
- G G Engineering
- 0.90 (+ 11.11)
- 20091512
- AvanceTechnologies
- 0.54 ( -8.47)
- 18780688
- YES Bank Ltd.
- 17.33 (+ 2.61)
- 14468025
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback